ÂÜÀòÂÒÂ×

Mark Bernstein is a seasoned professional with extensive experience in commercial operations and analytics within the pharmaceutical and financial sectors. Currently serving as Senior Director of Commercial Operations and Analytics at UroGen Pharma since 2020, Bernstein has held prominent roles at Novartis as Director of Business Partner for Oncology/Neuroscience Field Force Effectiveness, and at Pfizer in various director-level positions overseeing business operations, franchise strategy, and sales incentives. Bernstein's leadership experience includes a tenure as Chairman of the Board of Directors at Benchmark Federal Credit Union, guiding its transition to a community-based institution. Bernstein’s career began at Wyeth Pharmaceuticals, where impactful contributions were made in sales planning and analysis, earning recognition such as the Wyeth President’s Golden Circle Award. Educational qualifications include a B.S. in Computer Science from Penn State University and an MBA in Finance from Saint Joseph's University.